REVANCE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement (form 8-K)

bottom:0px;margin-top:12pt">FORM 8-K
 
 CURRENT REPORT
 Pursuant to Section 13 or 15(d)
 of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): January 10, 2020
 
Revance Therapeutics, Inc.
 (Exact name of registrant as specified in its charter)
 
Delaware
 
001-36297
 
77-0551645
(State or other jurisdiction
 of incorporation)
 
(Commission
 Share
        

                                            © Acquiremedia - 2020